Literature DB >> 17342404

Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.

Reiichiro Kuwahara1, Hiroki Saitsu, Mitsuhiko Abe, Akio Takata, Kazuo Tanaka, Teruko Hino, Tatsuya Ide, Ryoko Kuromatsu, Ken Tanikawa, Masayoshi Kage, Ryukichi Kumashiro, Michio Sata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342404     DOI: 10.1007/s10620-006-9113-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  41 in total

1.  A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group.

Authors:  E Orito; M Mizokami; H Sakugawa; K Michitaka; K Ishikawa; T Ichida; T Okanoue; H Yotsuyanagi; S Iino
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

2.  Is there a role for viruses in triggering autoimmune hepatitis?

Authors:  Sandro Vento; Francesca Cainelli
Journal:  Autoimmun Rev       Date:  2004-01       Impact factor: 9.754

3.  Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.

Authors:  J L Steinberg; W Yeo; S Zhong; J Y Chan; J S Tam; P K Chan; N W Leung; P J Johnson
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

4.  Autoimmune hepatitis type 1 after measles.

Authors:  S Vento; F Cainelli; T Ferraro; E Concia
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

6.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

7.  Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.

Authors:  I V Weller; M F Bassendine; A K Murray; A Craxi; H C Thomas; S Sherlock
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

8.  Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

9.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  C L Lai; R N Chien; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; P C Wu; J C Dent; J Barber; S L Stephenson; D F Gray
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245

10.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.